AstraZeneca PLC - Total Cash From Operating Activities

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Cash-From-Operating-Activities" stands at 15.14 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

AstraZeneca PLC's third quarter result of 5.13 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 51.62 percent compared to it's second quarter result.

Also, AstraZeneca PLC's third quarter result of 5.13 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 51.76 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AstraZeneca PLC's third quarter result of 15.14 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 13.08 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 33.58 percent compared to the value the year prior.
The 1 year change in percent is 33.58.
The 3 year change in percent is 71.50.
The 5 year change in percent is 245.98.
The 10 year change in percent is 229.49.

The Serie's long term average value is 6.57 Billion United States Dollars. It's latest available value, on 09/30/2025, is 130.31 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2018, to it's latest available value, on 09/30/2025, is +988.43%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.